Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke
- 20 November 1993
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 342 (8882), 1255-1262
- https://doi.org/10.1016/0140-6736(93)92358-z
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Atrial fibrillation and anticoagulation: from randomised trials to practiceThe Lancet, 1993
- Neurological commentHeart, 1992
- Design of a multicenter randomized trial for the Stroke Prevention in Atrial Fibrillation Study. The Stroke Prevention in Atrial Fibrillation Investigators.Stroke, 1990
- Interobserver agreement for the assessment of handicap in stroke patients.Stroke, 1989
- Interobserver agreement for the assessment of handicap in stroke patients.Stroke, 1988
- Secondary prevention of vascular disease by prolonged antiplatelet treatmentBMJ, 1988
- IS A CONTROLLED TRIAL OF LONG-TERM ORAL ANTICOAGULANTS IN PATIENTS WITH STROKE AND NON-RHEUMATIC ATRIAL FIBRILLATION WORTHWHILE?The Lancet, 1986
- Hemorrhagic complications of long-term anticoagulant therapy for ischemic cerebral vascular disease.Stroke, 1986
- Cause of cerebral infarction in the carotid territory. Its relation to the size and the location of the infarct and to the underlying vascular lesion.Stroke, 1985
- Immediate anticoagulation of embolic stroke: brain hemorrhage and management options. Cerebral Embolism Study Group.Stroke, 1984